Stories

Topic's Include: Mayo Clinic in Rochester eases visitor restrictions for pediatric hospital patients, and ask the Mayo Mom: More than 2 years of COVID-19 takes its toll on children, families.

Experts at Mayo Clinic have developed a unique method of testing that combines new technology with novel bioinformatics to promptly detect a group of uncommon genetic conditions that are often difficult to identify.

This week’s research roundup features: High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13.

Lying in an ICU bed as sick as he could get, Jon Bratsch thought he was past the point of no return. But when a Mayo Clinic Laboratories’ test revealed the source of his dire symptoms, everything changed. Today, Jon’s back to the life and family he loves.

Topic's Include: Study confirms effectiveness of COVID-19 booster vaccinations, history of infectious disease outbreaks and vaccines timeline, and Mayo Clinic minute: helping kids struggling with the ever-changing COVID-19 pandemic.

As a bid coordinator, Meredith Clark’s work helps expand testing capabilities for Mayo Clinic Laboratories clients, so they can offer the right test at the right time for the right patient.

Today's Topic Features: Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.

Topic's Include: Mayo Clinic expert discourages throat swab COVID-19 test ‘hack’, and midwest COVID-19 situation update/predictive modeling and what’s next?

Today's Topic Features: Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib.

A tenacious fighter, Joy Carol never lost hope that a mysterious condition that had stripped her of her ability to move would be identified. Hope turned into reality when a Mayo Clinic Laboratories test identified the cause of her illness and opened the door to successful treatment.

Topic's Include: Mayo Clinic Minute: Looking ahead after 2 years of COVID-19 pandemic, cancer treatment may inhibit immune response to COVID-19 vaccination, and Mayo Clinic Q&A- why getting infected with COVID-19 is still a bad idea.

Sainu Owusu-Afriyie has held a wide range of laboratory roles throughout her career at Mayo Clinic. Now she’s focused on strategic management, where the work can sometime be ambiguous, but the focus remains squarely on benefitting patients.

Today's Topic Features: Clinical, histological and molecular profiling of different stages of alcohol-related liver disease.